These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18343803)

  • 1. Polyene susceptibility is dependent on nitrogen source in the opportunistic pathogen Candida albicans.
    Oliver BG; Silver PM; White TC
    J Antimicrob Chemother; 2008 Jun; 61(6):1302-8. PubMed ID: 18343803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans.
    Barker KS; Crisp S; Wiederhold N; Lewis RE; Bareither B; Eckstein J; Barbuch R; Bard M; Rogers PD
    J Antimicrob Chemother; 2004 Aug; 54(2):376-85. PubMed ID: 15201233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans.
    Liu TT; Lee RE; Barker KS; Lee RE; Wei L; Homayouni R; Rogers PD
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2226-36. PubMed ID: 15917516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans.
    Ellepola AN; Khajah R; Jayatilake S; Samaranayake L; Sharma P; Khan Z
    J Appl Oral Sci; 2015; 23(4):412-8. PubMed ID: 26398514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mode of action of polyene antibiotics; induced potassium leakage in Candida albicans.
    Hammond SM; Lambert PA; Kliger BN
    J Gen Microbiol; 1974 Apr; 81(2):325-30. PubMed ID: 4599408
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of polyene antibiotics on protein synthesis by free and membrane-bound ribosomes of Candida albicans].
    Lishnevskaia EB; Belousova II; Rodygina TN; Tereshin IM
    Biokhimiia; 1976; 41(7):1169-75. PubMed ID: 793640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of two different growth media on the postantifungal effect induced by polyenes on Candida species.
    Shu M; Ellepola AN; Samaranayake LP
    J Clin Microbiol; 2001 Jul; 39(7):2732-5. PubMed ID: 11427609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE) and depresses the cell surface hydrophobicity of oral Candida albicans isolates.
    Egusa H; Ellepola AN; Nikawa H; Hamada T; Samaranayake LP
    J Oral Pathol Med; 2000 May; 29(5):206-13. PubMed ID: 10801037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyene resistant Candida albicans: a proposed nutritional influence.
    Hammond SM; Kliger BN
    Microbios; 1974 Apr; 10(38):97-101. PubMed ID: 4604922
    [No Abstract]   [Full Text] [Related]  

  • 10. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
    Sanati H; Belanger P; Fratti R; Ghannoum M
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2492-6. PubMed ID: 9371355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular phospholipase production of oral Candida albicans isolates from smokers, diabetics, asthmatics, denture wearers and healthy individuals following brief exposure to polyene, echinocandin and azole antimycotics.
    Ellepola AN; Samaranayake LP; Khan ZU
    Braz J Microbiol; 2016; 47(4):911-916. PubMed ID: 27522928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
    J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New nystatin-related antifungal polyene macrolides with altered polyol region generated via biosynthetic engineering of Streptomyces noursei.
    Brautaset T; Sletta H; Degnes KF; Sekurova ON; Bakke I; Volokhan O; Andreassen T; Ellingsen TE; Zotchev SB
    Appl Environ Microbiol; 2011 Sep; 77(18):6636-43. PubMed ID: 21764946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae.
    Young LY; Hull CM; Heitman J
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2717-24. PubMed ID: 12936965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The release of potassium ions from Candida albicans in the presence of polyene antibiotics.
    Gale EF
    J Gen Microbiol; 1974 Feb; 80(2):451-65. PubMed ID: 4596987
    [No Abstract]   [Full Text] [Related]  

  • 16. DEVELOPMENT OF RESISTANCE TO POLYENE ANTIBIOTICS IN CANDIDA ALBICANS.
    HEBEKA EK; SOLOTOROVSKY M
    J Bacteriol; 1965 Jun; 89(6):1533-9. PubMed ID: 14291593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nystatin-like Pseudonocardia polyene B1, a novel disaccharide-containing antifungal heptaene antibiotic.
    Kim HJ; Han CY; Park JS; Oh SH; Kang SH; Choi SS; Kim JM; Kwak JH; Kim ES
    Sci Rep; 2018 Sep; 8(1):13584. PubMed ID: 30206268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
    Anil S; Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.
    Kuhn DM; George T; Chandra J; Mukherjee PK; Ghannoum MA
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1773-80. PubMed ID: 12019089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
    Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga MT; Miranda Y; del Valle O; Cossum PA; Wallace TL
    J Antimicrob Chemother; 1999 Sep; 44(3):397-401. PubMed ID: 10511410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.